The Dilemma of Transplanting Wiskott-Aldrich Syndrome Patients to Transplant or not to Transplant
Keywords:
Wiskott-Aldrich Syndrome (WAS), Primary Immune Deficiency Disease (PIDD), Hematopoietic stem cell transplantation (HSCT)Abstract
References
Wiskott, A. (1937) Familiarer, angeborener Morbus Werlhofii? Mschr. Kinderheilk, 68: 212.
Aldrich, RA., Steinberg, AG., Campbell, DC. (1954) Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics, 13(2): 133-139.
Harfi, HA., Al-Malik, S., Tulba, A. (1992) Wiskott-Aldrich syndrome. Annals of Saudi medicine, 12(4): 355-361.
Al-Saud, B., Al-Muhsen, S., Al-Ghonaium, A., Al Gazlan, S., Al-Dhekri, H., Arnaout, R.M, et al. (2013) The spectrum of primary immunodeficiency diseases in a Saudi tertiary care hospital over two years. Journal of Allergy and Clinical Immunology, 131(2): AB156.
Al-Mousa, H., Al-Dakheel, G., Jabr, A., Elbadaoui, F., Abouelhoda, M., Baig, M., et al. (2018) High incidence of Severe Combined Immunodeficiency Disease in Saudi Arabia detected through combined TREC and next generation sequencing of newborn dried blood spots. Front Immunol, 9:782.
Ochs, HD., Slichter, SJ., Harker, LA., Von Behrens, WE., Clark, RA., Wedgwood, RJ. (1980) The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood, 55(2): 243-252.
Burns, S., Thrasher, AJ., Blundell, MP., Machesky, L., Jones, GE. (2001) Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood, 98(4): 1142-1149.
Locci, M., Draghici, E., Marangoni, F., Bosticardo, M., Catucci, M., Aiuti, A., et al. (2009) The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J Exp Med, 206(4): 735.
Astrakhan, A., Ochs, HD., Rawlings, DJ. (2009) Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J Immunol, 182(12): 7370-7380.
Maillard, MH., Cotta-de-Almeida, V., Takeshima, F., Nguyen, DD., Michetti, P., Nagler, C., et al. (2007) The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med, 204(2): 381-391.
Imai, K., Morio, T., Zhu, Y., Jin, Y., Itoh, S., Kajiwara, M., et al. (2004) Clinical course of patients with WASP gene mutations. Blood, 103(2): 456-464.
Sullivan, KE., Mullen, CA., Blaese, RM., Winkelstein, JA. (1994) A multiinstitutional survey of the Wischott Aldrich syndrome. J Pediatr, 125(6 Pt 1): 876-885.
Blundell, MP., Worth, A., Bouma, G., Thrasher, AJ. (2010) The Wiskott- Aldrich syndrome: The actin cytoskeleton and immune cell function. Dis Markers, 29(3-4): 157-175.
Orange, JS., Roy-Ghanta, S., Mace, EM., Maru, S., Rak, GD., Sanborn, KB., et al. (2011) IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J Clin Invest, 121(4): 1535-1548.
Westerberg, LS., de la Fuente, MA., Wermeling, F., Ochs, HD., Karlsson, MC., Snapper, SB., et al. (2008) WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function. Blood, 112(10): 4139- 4147.
Nikolov, NP., Shimizu, M., Cleland, S., Bailey, D., Aoki, J., Strom, T., et al. (2010) Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. Blood, 116(5): 740-747.
Rengan, R., Ochs, HD., Sweet, LI., Keil, ML., Gunning, WT., Lachant, NA., et al. (2000) Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood, 95(4): 1283- 1292.
Orange, JS., Ramesh, N., Remold-O’Donnell, E., Sasahara, Y., Koopman, L., Byrne, M., et al. (2002) Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cellactivating immunologic synapses. Proc Natl Acad Sci U S A, 99(17): 11351-11356.
Welch, MD., Mullins, RD. (2002) Cellular control of actin nucleation. Annu Rev Cell Dev Biol, 18: 247-288.
Badour, K., Zhang, J., Shi, F., McGavin, MK., Rampersad, V., Hardy, LA., et al. (2003) The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity, 18(1): 141-154.
Rudolph, MG., Bayer, P., Abo, A., Kuhlmann, J., Vetter, IR., Wittinghofer, A. (1998) The Cdc42/Rac interactive binding region motif of the Wiskott Aldrich syndrome protein (WASP) is necessary but not sufficient for tight binding to Cdc42 and structure formation. J Biol Chem, 273(29): 18067-18076.
Kim, AS., Kakalis, LT., Abdul-Manan, N., Liu, GA., Rosen, MK. (2000) Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature, 404(6774): 151-158.
Hall, A. (1998) Rho GTPases and the actin cytoskeleton. Science, 279(5350): 509-514.
Pai, SY., Notarangelo, LD. (2010) Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment. Immunol Allergy Clin N Am, 30(2): 179-194.
Ochs, HD., Filipovich, AH., Veys, P., Cowan, MJ., Kapoor, N. (2009) Wiskott- Aldrich syndrome: diagnosis, clinical and labratorymanifestations, and treatment. Biol Blood Marrow Transplant, 15(1 Suppl): 84-90.
Pai, SY., DeMartiis, D., Forino, C., Cavagnini, S., Lanfranchi, A., Giliani, S., et al. (2006) Stem cell transplantation for the Wiskott–Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation. Bone Marrow Transplantation, 38(10): 671–679.
Ozsahin, H., Cavazzana-Calvo, M., Notarangelo, LD., Schulz, A., Thrasher, AJ., Mazzolari, E., et al. (2008) Long-term outcome following hematopoietic stem-cell transplantation in Wiskott– Aldrich syndrome: collaborative study of the European Society for immunodeficiencies and European Group for blood and marrow. Blood, 111(1): 439-445.
Kobayashi, R., Ariga, T., Nonoyama, S., Kanegane, H., Tsuchiya, S., Morio, T., et al. (2006) Outcome in patients with Wiskott–Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. Br J Hematol, 135(3): 362–366.
Friedrich, W., Schutz, C., Schulz, A., Benninghoff, U., Hoenig, M. (2009) Results and long-term outcome in 39 patients with Wiskott–Aldrich syndrome transplanted from HLA-matched and -mismatched donors Immunol Res, 44: 18–24.
Antoine, C., Müller, S., Cant, A., Cavazzana-Calvo, M., Veys, P., Vossen, J., et al. (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet, 361(9357): 553–560.
